Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECILITH
NCT05237063Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Jan 2021
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoint: Number of patients with nephrolithiasis recurrence at 5 years. Started Jan 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05237063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05237063.